Cargando…
Tumor Cell “Slimming” Regulates Tumor Progression through PLCL1/UCP1‐Mediated Lipid Browning
Autores principales: | Xiong, Zhiyong, Xiao, Wen, Bao, Lin, Xiong, Wei, Xiao, Haibing, Qu, Yan, Yuan, Changfei, Ruan, Hailong, Cao, Qi, Wang, Keshan, Song, Zhengshuai, Wang, Cheng, Hu, Wenjun, Ru, Zeyuan, Tong, Junwei, Cheng, Gong, Xu, Tianbo, Meng, Xiangui, Shi, Jian, Chen, Zhixian, Yang, Hongmei, Chen, Ke, Zhang, Xiaoping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9108633/ https://www.ncbi.nlm.nih.gov/pubmed/35570839 http://dx.doi.org/10.1002/advs.202202011 |
Ejemplares similares
-
Tumor Cell “Slimming” Regulates Tumor Progression through PLCL1/UCP1‐Mediated Lipid Browning
por: Xiong, Zhiyong, et al.
Publicado: (2019) -
NNT‐induced tumor cell “slimming” reverses the pro‐carcinogenesis effect of HIF2a in tumors
por: Xiong, Zhiyong, et al.
Publicado: (2021) -
Overexpression of PLIN2 is a prognostic marker and attenuates tumor progression in clear cell renal cell carcinoma
por: Cao, Qi, et al.
Publicado: (2018) -
HIF2α promotes tumour growth in clear cell renal cell carcinoma by increasing the expression of NUDT1 to reduce oxidative stress
por: Shi, Jian, et al.
Publicado: (2021) -
Downregulation of ubiquitin-specific protease 2 possesses prognostic and diagnostic value and promotes the clear cell renal cell carcinoma progression
por: Meng, Xiangui, et al.
Publicado: (2020)